FindTrial
Sign In

To check the safety and effectiveness of fluid used on the other side of the membrane during dialysis containing varying amount of potassium to remove excess potassium from your blood.

Safety and efficacy of variable dialysate potassium in Hemodialysis patients with hyperkalemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020677
Enrollment
40
Registered
2019-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N186- End stage renal disease

Interventions

Intervention1: Randomized, prospective, parallel group: In the first group the dialysate bath will contain 2 mEq/L potassium for the first hour and 0 mEq/L for the next 3 hours. The second group will

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with serum potassium before dialysis >=5.5 mEq/L.

Exclusion criteria

Exclusion criteria: any previous history of coronary artery disease, congestive heart failure, arrhythmia, patients with serum potassium >=6.5 mEq/L before dialysis, patients on digitalis, pregnancy.

Design outcomes

Primary

MeasureTime frame
Safety(arrythmias) and efficacy(reduction in serum potassium levels) of variable dialysate potassium in Hemodialysis patients with hyperkalemiaTimepoint: 0,1,2,3 and 4 hours of dialysis—

Secondary

MeasureTime frame
noneTimepoint: none—

Countries

India

Contacts

Public ContactAbhilash Chandra

Dr.RMLIMS

acn393@gmail.com09935893823

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026